12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. MSP Recovery (LIFW), Know Labs (KNW), Orchestra BioMed Hldgs (OBIO), Akso Health Group (AHG), Iovance Biotherapeutics (IOVA), and Soleno Therapeutics (SLNO) saw gains, while Avalo Therapeutics (AVTX), PTC Therapeutics (PTCT), First Wave BioPharma (FWBI), Novo Integrated Sciences (NVOS), Ambrx Biopharma (AMAM), and SeaStar Medical Holding (ICU) experienced losses.
September 15, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group's shares rose 18.16% to $1.17. The market value of their outstanding shares is at $26.7 million.
The substantial increase in Akso Health Group's share price suggests a positive market sentiment, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Iovance Biotherapeutics's shares increased by 17.97% to $5.48. The market value of their outstanding shares is at $1.3 billion.
The significant increase in Iovance Biotherapeutics's share price indicates a positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Know Labs's shares moved upwards by 30.33% to $0.58. The market value of their outstanding shares is at $30.3 million.
The substantial increase in Know Labs's share price suggests a positive market sentiment, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
MSP Recovery's shares increased by 153.0% to $0.14. The market value of their outstanding shares is at $46.8 million.
The significant increase in MSP Recovery's share price indicates a positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Orchestra BioMed Hldgs's stock moved upwards by 19.78% to $6.78. The market value of their outstanding shares is at $242.3 million.
The significant increase in Orchestra BioMed Hldgs's stock price indicates a positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Soleno Therapeutics's stock moved upwards by 16.48% to $4.94. The company's market cap stands at $49.3 million.
The substantial increase in Soleno Therapeutics's stock price suggests a positive market sentiment, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Ambrx Biopharma's stock declined by 15.56% to $8.39. The market value of their outstanding shares is at $520.5 million.
The significant decrease in Ambrx Biopharma's stock price indicates a negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Avalo Therapeutics's stock fell 35.3% to $0.14. The market value of their outstanding shares is at $2.8 million.
The significant decrease in Avalo Therapeutics's stock price indicates a negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
First Wave BioPharma's stock fell 19.3% to $0.41. The company's market cap stands at $2.9 million.
The significant decrease in First Wave BioPharma's stock price indicates a negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SeaStar Medical Holding's stock declined by 14.27% to $0.2. The market value of their outstanding shares is at $3.9 million.
The substantial decrease in SeaStar Medical Holding's stock price suggests a negative market sentiment, which could result in further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Novo Integrated Sciences's stock fell 16.18% to $0.36. The company's market cap stands at $56.2 million.
The substantial decrease in Novo Integrated Sciences's stock price suggests a negative market sentiment, which could result in further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
PTC Therapeutics's shares fell 29.91% to $26.21. The company's market cap stands at $1.9 billion.
The substantial decrease in PTC Therapeutics's share price suggests a negative market sentiment, which could result in further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100